|
 |
lopinavir ritonavirThis page contains recent news articles, when available, and an overview of lopinavir ritonavir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.LIVALO has not been studied with the protease inhibitor combination lopinavir/ritonavir. LIVALO should not be used with this combination of protease ... AUTO-MOBI.info Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R ... - Dec 15, 2009 ...increased with concurrent administration of some other lipid-lowering therapies (fibrates or niacin), gemfibrozil, cyclosporine, or lopinavir/ritonavir. ... CNNMoney.com (press release) Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA ... - Dec 11, 2009 ...increased with concurrent administration of some other lipid-lowering therapies (fibrates or niacin), gemfibrozil, cyclosporine, or lopinavir/ritonavir. ... CNNMoney.com (press release) FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to ... - Nov 5, 2009 The following should be considered when initiating REYATAZ: In Study AI424-045, REYATAZ/ritonavir and lopinavir/ritonavir were similar for the primary ... WELT ONLINE FDA OKs Labeling Update for Reyataz Capsules - Nov 9, 2009 The Castle Study assessed a once-daily Reyataz/ritonavir (Reyataz/r)-based regimen versus a twice-daily lopinavir/ritonavir (LPV/r)-based regimen in ... Trading Markets (press release) What Risks Are Associated With High-Dose Rosuvastatin? - Oct 22, 2009 ...dose of 5 mg is recommended for patients of Asian ethnicity, patients with severe renal impairment, and patients taking concomitant lopinavir/ritonavir. ... Medscape El 37% de los españoles infectados por el VIH es diagnosticado tarde - Oct 21, 2009 Por un lado, un estudio liderado por investigadores españoles (José Ramón Arribas y Federico Pulido Ortega) indica que lopinavir-ritonavir es una opción ... elmundo.es El diagnóstico precoz y los nuevos fármacos contra el VIH/Sida, temas clave ... - Oct 21, 2009 En este campo, se presentarán datos del mayor estudio de pacientes en tratamiento con lopinavir/ritonavir en monoterapia, que demuestra que es una opción ... Europa Press Ritonavir Oral : Uses, Side Effects, Interactions, Pictures, Warnings... - Sep 30, 2008 This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD … with concurrent administration of rifabutin and lopinavir/ritonavir... - Oct 26, 2007 Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs 2006; 66: 1275–1299. | Article | PubMed | ISI | ChemPort | ... Nature.com Study Supports Popular HIV Drug Regimen - May 14, 2008 By Randy Dotinga. WEDNESDAY, May 14 (HealthDay News) -- The largest study of its kind supports the use of a popular three-drug regimen for HIV patients and ... Washington Post Abbott Holds Back AIDS Drug - Jul 5, 2006 ...“The result is that the new formulation of lopinavir/ritonavir remains unavailable and unaffordable for the vast majority of patients who need it,â€? said MSF ... Red Herring New Prezista(R) Phase 3 Study Meets Primary Objective of Non- - Jul 6, 2007 New Prezista(R) Phase 3 Study Meets Primary Objective of Non- Inferiority and Secondary Objective of Superiority in Virologic Response vs. ... BiznesNet … Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Riton... - Jul 11, 2005 Abbott announced today that it achieved its goals in negotiating an agreement with the government of Brazil regarding Kaletra(R) (lopinavir/ritonavir), ... Medical News Today - Medical News Today (press release) Atazanavir/Ritonavir Once Daily Effective in Treatment-Naive HIV... - Aug 5, 2008 August 5, 2008 — In treatment-naive patients with HIV infection, atazanavir/ritonavir once daily had similar antiviral efficacy to lopinavir/ritonavir twice ... Medscape … Approval for New Kaletra(R) (Lopinavir/Ritonavir) Tablet Formulatio... - Oct 31, 2005 ABBOTT PARK, Ill., Oct. 31 /PRNewswire-FirstCall/ -- Abbott announced today that it has received US Food and Drug Administration (FDA) approval for a new ... Free with registration - PR Newswire - AccessMyLibrary.com … Study Comparing Fosamprenavir to Lopinavir/Ritonavir Presented at... - Aug 17, 2006 TORONTO, CANADA -- August 17, 2006 -- This month, The Lancet published results of a study showing that HIV regimens using Lexiva (Telzir) Tablets+ritonavir ... DG News … -Ritonavir More Effective Than Lopinavir-Ritonavir in HIV-Infected,... - Jul 5, 2007 LONDON, UK -- July 5, 2007 -- Darunavir-ritonavir should be considered as a treatment option across the range of treatment-experienced patients with HIV ... DG News New Abbott Aluvia® Tablet for Treatment of HIV Available in South... - Jun 2, 2008 Abbott today announced that the new tablet formulation of its protease inhibitor Aluvia ® ( lopinavir/ritonavir), for the treatment of HIV-1, ... AllAfrica.com Lopinavir/ritonavir tablets - Nov 1, 2005 This tablet formulation of lopinavir and ritonavir provides several advantages over the capsule formulation, including: a reduced pill burden of 4 tablets ... Free with registration - Formulary - AccessMyLibrary.com A press release distributed by PR Newswire Europe - Apr 4, 2006 Abbott today announced that it has filed for registration of the new tablet formulation of its HIV medicine, lopinavir/ritonavir, in South Africa. ... prnewswire.co.uk Interaction between lopinavir/ritonavir and warfarin.(Case study) - Aug 14, 2007 Drug interactions involving protease inhibitors are common. Protease inhibitors are well known inhibitors of the 3A4 isozyme of cytochrome P450. ... Free with registration - CMAJ: Canadian Medical Association... - AccessMyLibrary.com Lopinavir/ritonavir not linked to hepatotoxicity regardless of HCV... - Jan 25, 2005 Use of lopinavir/ritonavir (Kaletra) is not associated with significant liver toxicity even in patients coinfected with the hepatitis C virus (HCV), ... Aidsmap Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower... - Jan 28, 2008 ABBOTT PARK, Ill., Jan. 28 /PRNewswire/ -- Abbott announced today that the European Committee for Medicinal Products for Human Use (CHMP), the scientific ... Free with registration - PR Newswire - AccessMyLibrary.com … To Expand Access And Affordability To Lopinavir/ritonavir In The... - Aug 20, 2006 Abbott today said that it is implementing new initiatives aimed at expanding access and affordability to its new lopinavir/ritonavir tablet in the ... Medical News Today - Medical News Today (press release) ICAAC: Studies in ART-Naive and Experienced HIV Patients - Dr. Paul … - Oct 25, 2007 The 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) attracted some 12000 delegates to Chicago, Illinois, September 17-20, ... Medscape Lopinavir-Ritonavir Tablets May Be Better Than Capsules - Jul 28, 2005 July 28, 2005 (Rio de Janeiro) -- A new formulation of lopinavir-ritonavir (Kaletra) as a tablet instead of the soft gel capsule or liquid preparation ... Medscape Africa: Access Denied to Crucial New HIV/Aids Medicines - Mar 15, 2006 Lagos/Berlin/New York — People living with HIV/AIDS in developing countries can?t get new and/or improved drugs that can make a critical difference, ... AllAfrica.com … Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir As... - Oct 28, 2008 Ninety-six week results presented from a phase 3, randomized, open-label, ongoing clinical trial showed that 79 percent of treatment-naive HIV-1 infected ... Medical News Today - Medical News Today (press release) … welcomes decision by Abbott Labs to reduce price of lopinavir/riton... - Apr 11, 2007 The World Health Organization (WHO) is committed to work towards universal access, by 2010, to HIV prevention services and to treatment and care for people ... News-Medical.net Lopinavir/ritonavir reduces lamotrigine plasma concentrations in... - Feb 14, 2006 Manon J. van der Lee, PharmD 1 , Lara Dawood 1 , Hadewych JM ter Hofstede, MD 1 , Marga JA de Graaff-Teulen 1 , Eleonora WJ van Ewijk-Beneken Kolmer 1 ... Nature.com Efavirenz May Be Best Initial Treatment of HIV-1 Infection - May 15, 2008 May 15, 2008 — In patients with HIV-1 infection, those given efavirenz plus 2 nucleoside reverse transcriptase inhibitors (NRTIs) were less likely to have ... Medscape Cost Effectiveness of Lopinavir/Ritonavir Compared with Atazanavir... - Aug 10, 2007 Objective: To estimate the cost effectiveness and long-term combined effects of HIV disease and antiretroviral (ARV) therapy-related risk for coronary heart ... Medscape Lopinavir-Ritonavir Oral: Dosage, Uses and Warnings - Oct 24, 2006 This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... Medscape Atazanavir/Ritonavir as Effective as Lopinavir/Ritonavir in HIV... - Aug 1, 2008 NEW YORK -- August 1, 2008 -- In HIV treatment-naïve patients, atazanavir/ritonavir (A/R) QD shows similar antiviral efficacy to lopinavir/ritonavir (L/R) ... DG News … Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Riton... - Jul 12, 2005 Abbott announced today that it achieved its goals in negotiating an agreement with the government of Brazil regarding Kaletra(R) (lopinavir/ritonavir), ... i-newswire.com … for New Lower-Strength Kaletra(R) and Aluvia(R) (lopinavir/ritonavi... - Jul 20, 2007 ABBOTT PARK, Ill., July 20 /PRNewswire-FirstCall/ -- Abbott announced today its next advancement in the fight against pediatric HIV/AIDS. ... Free with registration - PR Newswire - AccessMyLibrary.com … tablet formulation of Kaletra (lopinavir/ritonavir) receives... - Apr 28, 2006 Abbott announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), ... Pay-Per-View - Company Reports - Factiva, from Dow Jones … Achieves Superiority Over Lopinavir/Ritonavir in Suppressing Human... - Oct 28, 2008 By Ed Susman. WASHINGTON, DC -- October 28, 2008 -- Darunavir/ritonavir in combination with other anti-human immunodeficiency virus (HIV) drugs achieved ... DG News … Show a Kaletra(R) (Lopinavir/Ritonavir)-Based Regimen Demonstrated... - Nov 18, 2005 DUBLIN, Nov. 18 /PRNewswire-FirstCall/ -- The longest clinical study of any HIV treatment -- seven years (360 weeks) -- of Kaletra(R) ... biotech-intelligence.com Abbott and Government of Brazil Sign Kaletra® (lopinavir/ritonavir) … - Jul 7, 2007 ...he Government of Brazil has accepted Abbott's offer to supply Kaletra® (lopinavir/ritonavir) tablets at the equivalent of US$1000 per patient per year in ... webwire.com HIV/AIDS HAART; Lopinavir/ritonavir is safe and effective in pretreate... - Jan 2, 2006 2006 JAN 2 - (NewsRx.com) -- Lopinavir/ritonavir is safe and effective in heavily pretreated HIV-infected children. According to recent research from Spain, ... Pay-Per-View - Anti-Infectives Week - Factiva, from Dow Jones Efavirenz superior to lopinavir/ritonavir in very advanced HIV,... - Aug 6, 2008 Efavirenz treatment results in a significantly higher rate of viral suppression after 48 weeks when compared to lopinavir/ritonavir, investigators of a ... Aidsmap … Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Riton... - Sep 7, 2005 SAO PAULO, Brazil, July 9 /PRNewswire/ -- Abbott announced today that it achieved its goals in negotiating an agreement with the government of Brazil ... FinanzNachrichten.de … Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) - Nov 12, 2007 ABBOTT PARK, Ill., Nov. 12 /PRNewswire-FirstCall/ -- Abbott today announced that it has received US Food and Drug Administration (FDA) approval for a new ... Free with registration - PR Newswire - AccessMyLibrary.com Study Compares First-Line Drug Therapies For Treating HIV - Aug 20, 2006 In the first head-to-head comparison between two commonly used HIV treatments, researchers found one triple-drug therapy was significantly more effective at ... Medical News Today - Medical News Today (press release) Drug Criteria & Outcomes: New FDA Approvals. - Dec 1, 2005 ...• Nelarabine (Arranon) by GlaxoSmithKline. The FDA has approved nelarabine (Arranon) to treat adults and children with T-cell acute lymphoblastic leukemia ... Free with registration - Drug Formulary Review - AccessMyLibrary.com Study Compares First-Line Drug Therapies For Treating HIV - Aug 8, 2006 Newswise — In the first head-to-head comparison between two commonly used HIV treatments, researchers found one triple-drug therapy was significantly more ... newswise.com Lopinavir-Ritonavir Affects Pharmacokinetics of Irinotecan for Kaposi"... - May 1, 2008 By David Douglas. NEW YORK MAY 01, 2008 (Reuters Health) - In HIV patients with Kaposi"s sarcoma, use of lopinavir-ritonavir has a substantial impact on the ... Cancerpage.com Lopinavir/Ritonavir Monotherapy Suppresses HIV Replication in Central... - Mar 2, 2007 By Ed Susman. LOS ANGELES, CA -- March 2, 2007 -- Replication of HIV appears to be blocked in patients who are treated with lopinavir/ritonavir (Kaletra) ... DG News … Show a Kaletra(R) (Lopinavir/Ritonavir)-Based Regimen Demonstrated... - Nov 18, 2005 New Data Show a Kaletra(R) (Lopinavir/Ritonavir)-Based Regimen Demonstrated Continued Efficacy and Favorable Resistance Profile for Patients Through Seven ... Pay-Per-View - PR Newswire Europe - HighBeam Research Conflicting pharmacokinetic results when lopinavir and atazanavir are... - Jun 6, 2006 The double boosted combination of twice-daily lopinavir/ritonavir (Kaletra) with once-daily atazanavir (Reyataz) may significantly increase or reduce C min ... Aidsmap Alopecia induced by lopinavir plus ritonavir therapy in an HIV... - Jul 1, 2007 The most commonly reported side effects related to lopinavir/ritonavir are diarrhea, vomiting, headache, nausea, and increased serum triglycerides and ... $4.95 - Journal of Drugs in Dermatology - ECNext Atazanavir/Ritonavir Noninferior to Lopinavir/Ritonavir Over 96 Weeks... - Oct 30, 2008 By Ed Susman. WASHINGTON, DC -- October 30, 2008 -- A protease inhibitor-based regimen that includes boosted atazanavir demonstrated noninferiority after 96 ... DG News Generic ingredients: Lopinavir, Ritonavir - Dec 1, 2005 You will not be able to use Kaletra if you prove to be allergic to either lopinavir or ritonavir. Remember, too, that Kaletra must never be combined with ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com … Tablet Formulation of Kaletra'R', Lopinavir/Ritonavir, Approved In... - Sep 12, 2006 MONTREAL, QUEBEC--(CCNMatthews - Sept. 12, 2006) - Abbott Canada announced today that it has received marketing authorization from Health Canada for the ... marketwire.com Kaletra (Lopinavir/Ritonavir) Oral Solution - Healthcare Provider... - Aug 14, 2007 BETHESDA, MD -- August 14, 2007 -- Abbott Laboratories disseminated a Dear Healthcare Provider Letter throughout the world to physicians and pharmacists ... DG News … Study Evaluates PREZISTA(R)/ritonavir vs. lopinavir/ritonavir as... - Nov 18, 2008 BRIDGEWATER, NJ, Nov. 18 /PRNewswire/ -- Tibotec recently announced long-term study results from a phase 3 clinical trial, which compared PREZISTA(R) ... International Business Times Abbott And Government Of Brazil Sign Kaletra® (lopinavir / ritonavir)... - Jul 9, 2007 The Government of Brazil has accepted Abbott's offer to supply Kaletra® (lopinavir/ritonavir) tablets at the equivalent of US$1000 per patient per year in ... Medical News Today - Medical News Today (press release) First-line Approaches For Treating HIV Evaluated By Clinical Trial - Aug 15, 2006 In the first head-to-head comparison between two commonly used HIV treatments, researchers found one triple-drug therapy was significantly more effective at ... Medical News Today - Medical News Today (press release) Low-dose ritonavir almost entirely responsible for lipid increases... - Nov 9, 2005 The lipid disturbances often observed in HIV-positive individuals prescribed lopinavir/ritonavir (Kaletra) are almost entirely caused by the 100mg ... Aidsmap … Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for... - Nov 15, 2007 ABBOTT PARK, IL -- November 15, 2007 -- The US Food and Drug Administration (FDA) has approved a new lower-strength tablet formulation of the HIV protease ... DG News Once daily Kaletra: dose escalation rarely the answer for those with... - Jun 21, 2005 Even after dose escalation, plasma concentrations of once-daily Kaletra (lopinavir/ritonavir) rarely reach therapeutic levels in some patients, according to ... Aidsmap ABBOTT STATEMENT ON ADVANCING PEDIATRIC HIV TREATMENT. - Mar 14, 2006 ABBOTT PARK, Ill., March 13 /PRNewswire-AsiaNet/ - Following today's announcement of the US government's new public-private initiative for pediatric AIDS ... $4.95 - AsiaPulse News - ECNext Darunavir Not Inferior to Lopinavir in Treatment-Naive HIV Patients: ... - Sep 20, 2007 By Ed Susman. CHICAGO, IL -- September 20, 2007 -- The newly-approved protease inhibitor darunavir, boosted by ritonavir, appears to be noninferior to ... DG News … Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as... - Oct 26, 2008 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Kaletra monotherapy as effective as triple therapy for at least 18... - Aug 18, 2006 Following on from the results of the KalMo study, presented on Tuesday at the Sixteenth International AIDS Conference in Toronto, three more studies ... Aidsmap … Formulation of Kaletra(R) (Lopinavir/Ritonavir) Receives Positive... - Apr 28, 2006 Abbott's New Tablet Formulation of Kaletra(R) (Lopinavir/Ritonavir) Receives Positive Opinion From the European Medicines Agency. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Once-daily lopinavir/ritonavir effective in HIV - Nov 3, 2006 ...(Reuters Health)—In anti-HIV combination therapy, use of a once-daily lopinavir/ritonavir formulation (Kaletra, Abbott) appears as effective as twice-daily ... AIDSmeds.com HIV/AIDS Treatment News Abbott Statement on Advancing Pediatric HIV Treatment in Developing … - Mar 13, 2006 ABBOTT PARK, Ill., March 13 /PRNewswire/ -- Following today's announcement of the US government's new public-private initiative for pediatric AIDS treatment ... $4.95 - PR Newswire - ECNext Pitt study analyzes HIV drug cocktails - Aug 13, 2006 By Anita Srikameswaran, Pittsburgh Post-Gazette. A new clinical trial has found that one commonly prescribed triple-drug cocktail was more effective than ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette … ; Therapeutic drug monitoring simplified for twice-daily lopinavir/r... - Jan 1, 2005 2005 JAN 1 - (NewsRx.com & NewsRx.net) -- Therapeutic drug monitoring is simplified for twice-daily lopinavir/ritonavir. "Cost and inconvenience limit the ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Abbott cuts lopinavir price to $2200 for middle-income countries; new... - Aug 14, 2006 Abbott Laboratories announced today that it will sell the new tablet form of its protease inhibitor lopinavir/ritonavir under the name Aluvia at a price of ... Aidsmap Twice-daily boosted fosamprenavir non-inferior to twice-daily Kaletra... - May 23, 2006 GlaxoSmithKline (GSK) and Vertex Pharmaceuticals have announced preliminary results from their KLEAN study - a 48-week open-label head-to-head comparison of ... Aidsmap … Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as... - Oct 27, 2008 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research No Differences in Trial of Fosamprenavir/Ritonavir - Aug 21, 2006 August 21, 2006 (Toronto) — Data from a randomized 48-week study comparing fosamprenavir ( Lexiva, GlaxoSmithKline)/ritonavir (FPV/r) and ... Medscape Atazanavir/ritonavir as potent over two years as Kaletra, but has... - Mar 15, 2006 Atazanavir (Reyataz) with low dose ritonavir is as effective as Kaletra (lopinavir/ritonavir) at suppressing viral load over two years in ... Aidsmap Article: AIDS issue dominates Abbott Labs' annual meeting. - Chicago ... - Apr 27, 2007 AIDS issue dominates Abbott Labs' annual meeting. ... find Chicago Tribune (Chicago, IL) articles. Byline: Bruce Japsen CHICAGO _ Despite a flurry of ... Pay-Per-View - Chicago Tribune - HighBeam Research Clinical trial evaluates first-line approaches for treating HIV - Aug 12, 2006 Toronto, Aug. 12 -- In the first head-to-head comparison between two commonly used HIV treatments, researchers found one triple-drug therapy was ... eurekalert.org … Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower... - Jan 28, 2008 Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … : New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet... - Apr 7, 2008 New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research … Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower... - Jan 28, 2008 Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA. from PR Newswire ... Pay-Per-View - PR Newswire Europe - HighBeam Research Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily … - Aug 5, 2008 MEXICO CITY, Aug. 5 /PRNewswire-FirstCall/ -- Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's protease inhibitor ... RedOrbit New MSF report shows up to 500% price rise for less-toxic, WHO … - Jul 23, 2007 Reuters and AlertNet are not responsible for the content of this article or for any external internet sites. The views expressed are the author's alone. ... Reuters AlertNet Deal lowers price of second-line therapy and makes new paediatric … - Apr 29, 2008 Further reductions in the prices of generic versions of key second-line antiretroviral drugs were announced yesterday, thanks to an agreement negotiated by ... Aidsmap HIV/AIDS; Researchers' data from the United States and Japan advance ... - Sep 25, 2006 2006 SEP 25 - (NewsRx.com) -- Data on HIV/AIDS are outlined in reports from the United States and Japan. Study 1: Tumor susceptibility gene 101 variability ... Pay-Per-View - AIDS Vaccine Week - Factiva, from Dow Jones New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South … - Mar 6, 2008 Abbott (NYSE: ABT) today announced that the new tablet formulation of its protease inhibitor Aluvia(R) (lopinavir/ritonavir), for the treatment of HIV-1, ... ITNews |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |